<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211010052718N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-03</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the use of laryngeal mask airway (LMA) with tracheal tube to perform percutaneous dilatation tracheostomy (PDT) in brain trauma (TBI) patients.</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the use of laryngeal mask airway (LMA) with tracheal tube to perform percutaneous dilatation tracheostomy (PDT) in brain trauma (TBI) patients.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69600</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients after choosing and obtaining informed consent to participate in the study after explaining the steps of conducting the research using the Simple Random Allocation method using a table of random numbers by computer and online (using the website www.random.org/integres) as They were randomly divided into two groups, A and B, each of which had its own code. These codes were written on the final envelope in which the patient group was specified. Without knowing these codes, the research colleagues placed the patients in one of the two groups by selecting each envelope.</study_design>
      <phase>3</phase>
      <hc_freetext>Diffuse traumatic brain injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: patients who are ventilated with a laryngeal mask, first the Endotracheal tube(ETT) was removed and then a Laryngeal mask airway(LMA Classic™)  (purchased from Saba compani, Iran) or a disposable LMA was implanted. LMA size was 4 in women and 5 in men. Then the LMA was fixed with glue and the patient's head was pulled. Inspiratory pressure was adjusted to reduce excessive air leakage when necessary. The video bronchoscope was inserted into the trachea through the LMA and the thyroid and cricoid cartilages and the upper 3 cartilages of the trachea were identified. After this, the tip of the bronchoscope was placed zero to one centimeter below the vocal cords to observe the thyroid cartilage. Intervention 2: Control method: In patients who are ventilated with a tracheal tube, the cricoid and thyroid cartilages are touched and the position of the first tracheal cartilage is determined. Then the bronchoscope was inserted into the ETT up to the tip of the Endotracheal tube(ETT). After that, the ETT (purchased from Saba compani, Iran) and the bronchoscope were placed directly above the specified position. This step was seen by transillumination and supported by another person responsible for positioning and stabilizing the ETT. Besides inspiratory pressure, ventilation variables were not modified. ETT size in women was 7.5-0.7 mm (inner diameter) and in men 0.8-7.5 mm. Percutaneous dilatational tracheostomy(PDT) was performed according to the Griggs method (31). After cutting the skin, the tracheal hole was guided by bronchoscopy to the midline of the trachea under the first or second tracheal cartilage. With the guidance of the guidewire, the dilatation process was checked with the Griggs dilating forceps and the guidance of the tracheostomy tube was also checked bronchoscopically. Before connecting to the ventilator, the intratracheal position of the cannula was confirmed by tracheobronchoscopy through the tracheostomy tube.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I have not decided</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Nikzad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Amir Mazandarani Blvd.</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>33131 - 48166</zip>
        <telephone>+98 11 3336 1700</telephone>
        <email>A.NIKZAD@MAZUMS.AC</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Nikzad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Amir Mazandarani Blvd.</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>33131 - 48166</zip>
        <telephone>+98 11 3336 1700</telephone>
        <email>A.NIKZAD@MAZUMS.AC</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with brain injury hospitalized in the intensive care unit who need long-term respiratory care</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who had contraindications for Percutaneous DilatedTracheostomy included inadequate and difficult airway
Patients who had contraindications forPercutaneous DilatedTracheostomy included obese subjects
Patients with contraindications for Percutaneous DilatedTracheostomy included potentially difficult endotracheal intubation
Patients with contraindications forPercutaneous DilatedTracheostomy included oxygenation index (Pascal  Oxygen2/Fraction of Inspired Oxygen2) less than 200
Patients with contraindications for Percutaneous DilatedTracheostomy included positive end-expiratory pressure (Positive end-expiratory pressure ) ≥15 mbar</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S06.2X</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diffuse traumatic brain injury</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: patients who are ventilated with a laryngeal mask, first the Endotracheal tube(ETT) was removed and then a Laryngeal mask airway(LMA Classic™)  (purchased from Saba compani, Iran) or a disposable LMA was implanted. LMA size was 4 in women and 5 in men. Then the LMA was fixed with glue and the patient's head was pulled. Inspiratory pressure was adjusted to reduce excessive air leakage when necessary. The video bronchoscope was inserted into the trachea through the LMA and the thyroid and cricoid cartilages and the upper 3 cartilages of the trachea were identified. After this, the tip of the bronchoscope was placed zero to one centimeter below the vocal cords to observe the thyroid cartilage.</i_keyword>
      <i_keyword>Control method: In patients who are ventilated with a tracheal tube, the cricoid and thyroid cartilages are touched and the position of the first tracheal cartilage is determined. Then the bronchoscope was inserted into the ETT up to the tip of the Endotracheal tube(ETT). After that, the ETT (purchased from Saba compani, Iran) and the bronchoscope were placed directly above the specified position. This step was seen by transillumination and supported by another person responsible for positioning and stabilizing the ETT. Besides inspiratory pressure, ventilation variables were not modified. ETT size in women was 7.5-0.7 mm (inner diameter) and in men 0.8-7.5 mm. Percutaneous dilatational tracheostomy(PDT) was performed according to the Griggs method (31). After cutting the skin, the tracheal hole was guided by bronchoscopy to the midline of the trachea under the first or second tracheal cartilage. With the guidance of the guidewire, the dilatation process was checked with the Griggs dilating forceps and the guidance of the tracheostomy tube was also checked bronchoscopically. Before connecting to the ventilator, the intratracheal position of the cannula was confirmed by tracheobronchoscopy through the tracheostomy tube.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Determining the quality of tracheostomy. Timepoint: Before and after the presser. Method of measurement: Arterial blood gas levels.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Comparison of the amount of time of two methods. Timepoint: before and after. Method of measurement: Record the time of the procedure from the beginning to the end.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-14</approval_date>
        <contact_name>Ethics Committee of Imam Khomeini Hospital of Sari - Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Office Building Ethics Committee of Imam Khomeini Hospital Amir Mazandarani Blvd. Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
